Edgewise Therapeutics Price Target Maintained With a $48.00/Share by Piper Sandler

Edgewise Therapeutics Price Target Maintained With a $48.00/Share by Piper Sandler

Dow JonesJul 1 21:57

Piper Sandler Maintains Overweight on Edgewise Therapeutics, Maintains $48 Price Target

Piper Sandler analyst Yasmeen Rahimi maintains Edgewise Therapeutics (NASDAQ:EWTX) with a Overweight and maintains $48 price target.

BenzingaJul 1 21:47

Piper Sandler Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $48

Piper Sandler analyst Yasmeen Rahimi maintains $Edgewise Therapeutics(EWTX.US)$ with a buy rating, and maintains the target price at $48.According to TipRanks data, the analyst has a success rate of 3

Futu NewsJul 1 19:31 · Ratings

Edgewise Therapeutics (EWTX) Gets a Buy From Piper Sandler

TipRanksJul 1 18:36

Wedbush Reiterates Outperform on Edgewise Therapeutics, Maintains $31 Price Target

Wedbush analyst Laura Chico reiterates Edgewise Therapeutics (NASDAQ:EWTX) with a Outperform and maintains $31 price target.

BenzingaJun 26 22:22

Edgewise Therapeutics Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/26/2024 76.84% Wedbush $31 → $31 Reiterates Outperform → Outperform 04/22/2024 82.54% RBC Capital $28 →

BenzingaJun 26 22:20